Back to Search
MATTHEW DUNCAN BAER MD
MD
Family Medicine Physician
NPI: 1669009361IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD61326916(WA)
Education
CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2020
Research & Publications (20)
The methamphetamine-sensitive circadian oscillator does not employ canonical clock genes.
PMID 19204282·Proc Natl Acad Sci U S A·2009
7-preclinical
An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity.
PMID 19103766·Infect Immun·2009
7-preclinical
No confinement needed: observation of a metastable hydrophobic wetting two-layer ice on graphene.
PMID 19670866·J Am Chem Soc·2009
8-other
Intralines of quasi-conical intersections on torsion planes: methylamine as a case study.
PMID 19462985·J Phys Chem A·2009
8-other
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
PMID 19108889·Leuk Res·2009
3-trial
Leukemic blast and natural killer cell P-glycoprotein function and inhibition in a clinical trial of zosuquidar infusion in acute myeloid leukemia.
PMID 18976810·Leuk Res·2009
3-trial
Systemic mastocytosis: classification, pathogenesis, diagnosis, and treatment.
PMID 19271568·Cutis·2009
5-case
Photodissociation of H2(+) upon exposure to an intense pulsed photonic Fock state.
PMID 19552475·J Phys Chem A·2009
8-other
Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma.
PMID 19671864·Clin Cancer Res·2009
3-trial
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.
PMID 19528372·J Clin Oncol·2009
3-trial
Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML).
PMID 17881052·Leuk Res·2008
8-other
Natural history of osteonecrosis of the jaw in patients with multiple myeloma.
PMID 19018084·J Clin Oncol·2008
8-other
Spectral signatures of the pentagonal water cluster in bacteriorhodopsin.
PMID 19025752·Chemphyschem·2008
8-other
p53-inducible ribonucleotide reductase (p53R2/RRM2B) is a DNA hypomethylation-independent decitabine gene target that correlates with clinical response in myelodysplastic syndrome/acute myelogenous leukemia.
PMID 19010910·Cancer Res·2008
8-other
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.
PMID 18559874·J Clin Oncol·2008
8-other
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720.
PMID 18591543·J Clin Oncol·2008
3-trial
T/B and not T/B: high frequency of B-cell dyscrasias in T-LGL leukemia.
PMID 18464104·Leuk Lymphoma·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 3015 SQUALICUM PKWY STE 120
BELLINGHAM, WA 98225 - Phone
- (360) 676-9336
Quick Facts
- NPI
- 1669009361
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile